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Introduction
Gastro-oesophageal reﬂux disease (GERD) is a highly
prevalent condition that is associated with a diverse
range of symptoms, of which heartburn and regurgi-
tation are most common (1,2). GERD is routinely
encountered by physicians in daily practice (3).
Physicians generally appreciate that diagnosed
GERD patients are a heterogeneous population with
different needs. Indeed, the symptoms of GERD may
be either relatively mild or infrequent in some
patients, while in others they can be sufﬁciently
bothersome to disrupt the individual’s physical,
social and emotional well-being, necessitating aggres-
sive treatment (4,5). As such, a variety of therapeutic
options are available for the treatment of GERD,
ranging from lifestyle modiﬁcations and over-the-
counter (OTC) agents to prescription acid-suppres-
sive therapy (6).
Optimal management of GERD in clinical practice
aims to alleviate symptoms, heal erosions, prevent
long-term complications (in at-risk patients) and
improve patient well-being. Acid-suppressive therapy
with proton pump inhibitors (PPIs) is generally
regarded as the treatment of choice in this regard
because of well-documented efﬁcacy and favourable
tolerability (6). However, self-medication with OTC
agents such as antacids is common, even among
patients receiving prescription therapy. A recent sur-
vey of GERD patients, for example, found that
20.5% were taking some form of OTC medication in
addition to their prescription therapy (7). This may
be explained by the fact that the symptoms and
impact on quality of life associated with GERD often
persists despite treatment (1,7,8). Reliance on OTC
medication may also be related to the widespread
perception among GERD sufferers that it is a trivial
disease without long-term health consequences (9).
SUMMARY
Objective: To determine whether patients with gastro-oesophageal reﬂux disease
(GERD) can be grouped according to the physical and psychological impact of their
disease. Methods: In this multinational study, 7713 primary care physicians
(PCPs) and gastrointestinal (GI) specialists took part in a structured online survey
to determine how they perceive the clinical and psychological needs of their GERD
patients, based on their three most recent consultations. Patients were grouped
according to one of the ﬁve clusters that were subjectively developed based on
preceding qualitative research. Results: Findings are reported for 1157 respon-
dents (875 PCPs, 282 GI specialists), who reviewed 3471 patient records. Two of
the ﬁve original clusters were collapsed because of overlapping characteristics, giv-
ing rise to three patient clusters. Patients with ‘long-term, disrupting GERD’ (39%)
had symptoms considered to have not only high physical but also psychological
impact. Patients with ‘recurrent, distressing GERD’ (14%) experienced both physical
and psychological impact and were worried about the recurrent, restrictive nature
of their disease or the possibility of having a more serious underlying condition.
Patients with ‘inconveniencing GERD’ (48%) had less frequent symptoms with
overall lower impact. Overall, there was a trend for GI specialists to more likely
see patients at higher clinical need than PCPs. Conclusions: Patients with GERD
can generally be classiﬁed according to the physical and psychological impact of
their disease. Recognition that such patients have different needs may facilitate
improved management of GERD by allowing treatment to be tailored according to
the patient’s need.
What’s known
• Physicians generally appreciate that patients
diagnosed with gastro-oesophageal reﬂux disease
(GERD) are a heterogeneous population with
therapeutic needs that differ according to the
impact of their disease.
• However, the management of GERD remains far
from optimal, as highlighted by prevalent self-
medication with over-the-counter agents even
among patients receiving prescription therapy.
What’s new
• The ﬁndings of this survey of primary care
physicians and gastrointestinal specialists indicate
that patients with GERD can generally be
grouped according to the perceived physical and
psychological impact of their disease.
• Recognition that such patients have different
needs, through understanding of the three
population clusters identiﬁed in this study, may
facilitate improved management of GERD by
allowing treatment to be tailored according to
the patient’s need.
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improved management of GERD in clinical practice.
This study aimed to determine whether cluster analy-
sis of patients with GERD, in terms of physician-per-
ceived clinical and emotional needs, would create a
foundation for improved patient management by
allowing treatment to be tailored according to the
patient’s need.
Methods
A survey was conducted to gather data on how phy-
sicians perceive the clinical and emotional needs of
their GERD patients. Physicians [primary care physi-
cians (PCPs) and gastrointestinal (GI) specialists] in
France, Germany, Italy, the UK and the USA took
part in the research, which was preceded by an initial
qualitative phase during which in-depth interviews
were conducted to establish how physicians treat
GERD and their perceptions of the treatment goals
and priorities for different patients (unpublished
observations). On the basis of this research, ﬁve
patient clusters were subjectively described:
1 Patients with occasional, but inconvenient symp-
toms of GERD where the patient demands an
instant solution.
2 Patients with intermittent, bothersome symptoms
of GERD that are likely to be attributed to lifestyle
issues.
3 Patients with recurrent, persistent symptoms of
GERD, for whom the current medication provides
inadequate relief of symptoms and where the
patient may be worried about their condition.
4 Patients with symptoms of GERD that have per-
sisted for a long time; symptoms may be con-
trolled by medication but return if PPIs are
discontinued and there is a concern about long-
term complications.
5 Patients with disruptive symptoms of GERD who
have current evidence of disease.
These ﬁve clusters were used to develop pen por-
traits that were used in this quantitative research, in
which a secured web-link was sent to 7713 PCPs and
GI specialists in the participating countries (quotas
having been set to ensure a representative sample of
physicians in each country). A small ﬁnancial incen-
tive, commensurate with the length of the question-
naire, was offered as part of completing the survey,
and reminders were sent once the web-link had been
conveyed to potential participants to speed up
recruitment and completion of the survey. Physicians
were ﬁrst asked to complete a number of screening
questions, to determine their suitability for inclusion
in the study. Only those physicians whose year of
qualiﬁcation in their particular specialty were
between 1976 and 2002, and were actively treating
patients with acid-related disorders, were allowed to
participate. Further screening criteria were based on
PPI prescription volume; PCPs were required to have
written at least 10 PPI prescriptions for acid-related
disorders in the last 4 weeks, while GI specialists
must have written at least 20 PPI prescriptions in the
same time period.
As part of the online survey, eligible physicians
were subsequently asked to recall the last three
patients with GERD whom they had treated. For
each patient, physicians were asked to evaluate state-
ments concerning each patient’s physical and psycho-
logical impact of GERD and their attitudes to their
disease, using six-point Likert scales (Table 1), and
Table 1 Characteristics for evaluation of the physical and psychological impact of GERD and patients’ attitudes to
their disease
Frequency of symptoms (1 = frequent; 6 = occasional)
Severity of symptoms (1 = severe; 6 = mild)
Relationship of symptoms to the patient (1 = symptoms are linked to patient behaviour; 6 = symptoms are disease related)
Risk of future erosions or complications (1 = high; 6 = low)
Level of symptom control (1 = not controlled; 6 = controlled)
History of GERD (1 = long-time sufferer; 6 = only started to suffer from symptoms recently)
Level of anxiety about symptoms (1 = anxious; 6 = not anxious)
Level of patient distress (1 = clearly distressed; 6 = not distressed)
Disruption associated with symptoms (1 = very disruptive; 6 = low)
Physical evidence of disease (1 = physical evidence; 6 = no current physical evidence)
Level of patient interest in learning about his⁄her condition (1 = none; 6 = active interest)
Patient’s likelihood to comply with physician’s recommendations (1 = not likely to comply; 6 = likely to comply)
Level of sleep disruption (1 = disrupted; 6 = not disrupted)
GERD, gastro-oesophageal reﬂux disease.
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ters outlined above. The physical impact of GERD
was determined subjectively based on responses to
statements evaluating symptom frequency, severity,
risk of future erosions⁄complications, level of symp-
tom control, history of GERD and physical evidence
of the disease. The psychological disease impact was
similarly determined based on responses to state-
ments on the relationship of symptoms to the
patient, levels of anxiety about symptoms, patient
distress, symptom-related disruption, patients’ inter-
est in learning about their condition and likelihood
of compliance with physician recommendations. All
data were analysed descriptively.
Results
A total of 1157 physicians (875 PCPs, 282 GI special-
ists) participated in the study (15% response rate),
and around 30% were from the USA (Table 2). In
accordance with the screening criteria, the majority
of PCPs (97%) had written at least 10 PPI prescrip-
tions for acid-related disorders in the last 4 weeks,
while 89% of GI specialists had written at least 20
PPI prescriptions in the same time period. The most
commonly prescribed PPI for both physician groups
was generic omeprazole.
A total of 3471 patient records were reviewed, and
physicians were able to classify all of their patients
according to one of the ﬁve pen portraits. Clusters 1
and 2 showed overlapping characteristics, as did
clusters 4 and 5. Based on the evaluation of physi-
cian-perceived impact of GERD on physical and
psychological dimensions, therefore, the clusters were
reduced to the following three (Figure 1):
• Patients with ‘long-term, disrupting GERD’.
• Patients with ‘recurrent, distressing GERD’.
• Patients with ‘inconveniencing GERD’.
Overall, there was a trend for GI specialists to
more likely see patients at highest clinical need (i.e.
patients with high physical and psychological impact)
than PCPs (Figure 2), and there were no relevant
by-country differences.
Patients with ‘long-term, disrupting GERD’
Patients in this cluster, which accounted for over
one-third of the GERD patient population (39%;
Europe, 40%; USA, 35%), had suffered GERD symp-
toms for a long time (59% of patients had experi-
enced symptoms for > 2 years) and, compared with
the other clusters, had more frequent or severe
symptoms that were disrupting daily life (Table 3).
Consequently, such symptoms were perceived by
physicians to confer high physical impact as well as
psychological impact. Overall, patients in this cluster
either already had complications or had a high risk
of future complications. Indeed, when asked to
describe such patients in terms of ‘high-risk of future
complications’, physicians felt that this statement
described 36.5% of evaluable patients in this cluster
(Table 3).
Patients with ‘recurrent, distressing GERD’
Patients in this cluster accounted for the smallest
portion of the GERD population (14%; Europe,
13%; USA, 16%). Overall, physicians felt that such
patients were distressed by their GERD symptoms,
having physical but also psychological impact. Com-
pared with the other clusters, physicians noted that
these patients were unhappy about the recurrent and
restrictive nature of their disease and were more
likely to be worried that their symptoms were indica-
tive of something more serious (Table 3). Physicians
often described these patients as wanting to ‘take
control of their symptoms’.
Patients with ‘inconveniencing GERD’
Patients in this cluster accounted for the largest pro-
portion of the GERD patient population (48%; Eur-
ope, 47%; USA, 48%). Generally, these patients
experienced less frequent and⁄or relatively mild
symptoms, with lower impact, that could be ade-
quately controlled with the therapy they were cur-
rently treated with. Symptoms were perceived by the
physician to be mostly related to lifestyle, to a greater
extent than in other clusters. Levels of anxiety and
distress also tended to be lower in this group, who
were perceived by physicians to have a low risk of
future complications (Table 3).
Table 2 Characteristics of physicians who participated
in the study
Primary
care
physicians
(n = 875)
Gastrointestinal
specialists
(n = 282)
Country, n (%)
France 160 (18) 56 (20)
Germany 154 (18) 54 (19)
Italy 155 (18) 45 (16)
UK 177 (20) 60 (21)
USA 229 (26) 77 (27)
Year of qualiﬁcation, n (%)
1976 to 1985 358 (41) 73 (26)
1986 to 1995 345 (39) 108 (38)
1996 to 2002 172 (20) 101 (36)
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This multinational survey demonstrates that physi-
cians can generally classify GERD patients according
to one of the three clusters, based on the physician-
perceived impact of the disease on their physical and
psychological characteristics that, in turn, inﬂuence
their therapeutic needs. Given that previous research
demonstrates that many GERD patients experience
persistent symptoms despite prescription and⁄or
OTC therapy (7,8), such ﬁndings could, therefore,
facilitate improved patient management by allowing
treatment to be tailored according to the patient’s
need.
Around half of the GERD population (53%) were
the combined cohort of patients with ‘long-term,
disrupting GERD’ and ‘recurrent, distressing GERD’.
In view of the impact of the disease on their quality
of life, such patients require adequate therapy to
control their symptoms along with reassurance and
education to address any frustrations and anxieties
about their disease. However, these patients represent
a challenge to physicians in terms of meeting these
management goals. Patient-reported questionnaires
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Figure 2 Distribution of patient clusters, according to physician proﬁle
Figure 1 Stylistic interpretation of the two-dimensional spectrum of physical and psychological impact in patients with
GERD, according to patient cluster
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recently the GERD Questionnaire (GerdQ) (11) may
be useful in this regard, by allowing physicians to
quickly establish the impact of GERD and, in turn,
the most appropriate treatment. GerdQ, for example,
uses six questions regarding heartburn, regurgitation,
epigastric pain, nausea, sleep disturbance and OTC
medication use to identify patients with a high likeli-
hood of GERD and those most impacted by their
disease. A PPI that provides predictable and long-
lasting control of GERD symptoms represents a logi-
cal choice for such patients.
With regard to cluster terminology, it is important
to consider that the three clusters are not mutually
exclusive and certainly for the ‘disrupting’ and ‘dis-
tressing’ categories, there is potential scope for over-
lap. Adopting an overall terminology to reﬂect these
clusters was somewhat difﬁcult. However, the notable
difference is that those with ‘disrupting GERD’ had
generally reached a point at which they were accept-
ing of their symptoms. In contrast, the ‘distressed
GERD’ cluster was characterised by the recurrent
nature of their symptoms and a high level of distress
related to restrictions on their daily lives.
Some 48% of the surveyed patient population had
‘inconveniencing GERD’, in that symptoms were
occasional and⁄or mild, with low impact, and were
perceived by physicians to be mostly related to life-
style. These patients typically required an ‘instant
solution’ to their symptoms, and OTC therapy with
an antacid, or on-demand use of a prescription acid-
suppressive agent, would seem appropriate to meet
their needs. However, such patients should be
encouraged to seek appropriate medical care should
their symptoms become more troublesome (in terms
of frequency and severity) and daily life is impaired.
Limitations of this study include the potential
bias towards physicians willing to participate in sur-
vey research, and a possibly uneven balance of con-
tributors (in that only 24% of participants were GI
specialists; the remainder were PCPs). Also, consid-
ering the fact that the patient clusters were derived
from physicians’ perceptions of their patients’ clini-
cal and emotional needs, the observation of a large
proportion of patients with ‘inconveniencing GERD’
may have arisen from the tendency of physicians to
underestimate the severity and impact of GERD
symptoms, as shown previously (12). This limitation
may have been addressed by validation of physi-
cians’ perceptions against patients’ perceptions and
experiences of GERD, which could form the basis
of further research. However, it should be recogni-
sed that the present analysis attempted to overcome
this limitation by evaluating physician responses on
Table 3 Statement agreement (physicians’ perceptions)
Cluster, % (n)
‘Inconveniencing
GERD’
(n = 1653)
‘Recurrent,
distressing
GERD’
(n = 473)
‘Long-term,
disrupting GERD’
(n = 1345)
Frequent symptoms 15.7 (260) 32.6 (154) 38.9 (523)
Severe symptoms 15.7 (259) 23.5 (111) 30.6 (411)
Symptoms are linked to patient behaviour 29.0 (479) 17.5 (83) 16.4 (221)
High risk of future complications 14.8 (244) 22.4 (106) 36.5 (491)
Symptoms are not controlled 18.3 (302) 26.6 (126) 26.0 (350)
Long-term sufferer of GERD symptoms 18.4 (304) 29.6 (140) 41.1 (553)
Patient is anxious about symptoms 20.1 (333) 31.5 (149) 30.5 (410)
Patient is clearly distressed 19.4 (320) 31.1 (147) 28.3 (381)
Symptoms are very disruptive 16.5 (272) 28.3 (134) 27.0 (363)
Physical evidence of disease 17.6 (291) 19.5 (92) 29.3 (394)
Patient has their sleep disrupted 17.3 (286) 22.6 (107) 25.9 (349)
Patient feels that his⁄her symptoms are largely attributable to lifestyle 6.8 (113) 4.0 (19) 3.9 (52)
Patient is very frustrated by their GERD and feels they can no longer cope 2.6 (43) 5.9 (28) 4.8 (64)
Patient feels unhappy because the disease restricts his⁄her life 3.9 (64) 8.9 (42) 6.9 (93)
Patient sometimes worries that there might be something
more serious underlying their symptoms
5.1 (85) 13.5 (64) 12.9 (174)
Patient demands an ‘instant’ solution 16.9 (280) 9.7 (46) 12.3 (165)
GERD, gastro-oesophageal reﬂux disease.
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physical evidence of disease, frequency and severity
of symptoms and associated disruption. Other pos-
sible limitations include the relatively low response
rate (15%), but this was deemed acceptable for this
type of research. There was also the possibility of
‘forced’ classiﬁcation of patients into one of the ﬁve
patient clusters identiﬁed as part of the preceding
qualitative research. However, physicians were able
to classify all of their patients according to one or
the other of the ﬁve pen portraits, suggesting that
the qualitative hypothesis was strong. Additionally,
there may have been an over-representation of
patients who visited their physician more frequently
and, therefore, had a higher chance of being
recalled by the physician than patients who rarely
sought medical care.
Conclusion
In summary, patients presenting to their physician
with GERD can generally be classiﬁed as having
‘long-term, disrupting GERD’, ‘recurrent, distressing
GERD’ or ‘inconveniencing GERD’, based on the
physician-perceived impact of the disease on physical
and psychological characteristics. Recognition and
understanding of these population clusters may facil-
itate improved management of patients with GERD
by allowing treatment to be tailored according to the
patient’s need.
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